Press release
RNAi Pesticides Market Survey Detailed Analysis and Forecast 2025-2034
The RNAi Pesticides Market is estimated to reach over USD 4.6 billion by 2034, exhibiting a CAGR of 14.2% during the forecast period.
Request for free Sample Pages:
https://www.insightaceanalytic.com/request-sample/2799
RNA interference (RNAi) pesticides represent an innovative class of biopesticides that function by selectively silencing genes critical to the survival of agricultural pests. This technology utilizes RNAi-a naturally occurring biological process that regulates gene expression by preventing the translation of targeted messenger RNA (mRNA), thereby inhibiting the production of essential proteins. RNAi-based pesticides are engineered for high specificity, targeting only pest organisms while minimizing risks to non-target species such as beneficial insects and animals. These products are under development to manage a broad spectrum of crop-damaging pests, including nematodes, fungi, and insects.
As the agricultural sector evolves toward more sustainable and technologically advanced practices, the demand for RNAi insecticides continues to grow. Modern agricultural enterprises are increasingly adopting sophisticated pest control solutions to comply with regulatory requirements and meet consumer expectations for environmentally responsible food production. RNAi pesticides offer a promising solution by delivering targeted, effective pest management in alignment with global sustainability objectives.
List of Prominent Players in the RNAi Pesticides Market:
• Bayer
• Cibus
• DuPont
• RNAiSSANCE AG
• Syngenta Crop Protection AG
• GreenLight Biosciences, Inc.
• TRILLIUM AG
• Innatrix Inc.
• Renaissance BioScience Corp.
• Pebble Labs
• AgroSpheres
• Vestaron Corporation
• Elemental Enzymes Inc.
• Invaio Sciences, Inc
Market Dynamics:
Drivers:
Rising environmental concerns related to conventional chemical pesticides have significantly boosted the demand for sustainable alternatives. RNAi pesticides offer a highly targeted mode of action by silencing specific genes essential for pest survival, thereby reducing collateral impact on beneficial organisms, animals, and humans. This precision aligns well with global agricultural sustainability goals. Furthermore, ongoing advancements in RNAi delivery technologies-particularly the topical application of double-stranded RNA (dsRNA)-are enhancing the feasibility and cost-efficiency of RNAi pesticides for commercial-scale implementation.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/2799
Challenges:
A key hurdle in the adoption of RNAi pesticides is the lack of awareness among farmers and agricultural professionals regarding their benefits and functional mechanisms. Overcoming this gap requires dedicated educational initiatives and outreach programs.
Regional Trends:
North America currently holds the largest market share, driven by increased emphasis on sustainable farming practices and growing regulatory and consumer pressure to reduce chemical pesticide use. RNAi pesticides are gaining traction as they meet these environmental and safety standards. Meanwhile, the Asia-Pacific region-particularly nations like China and India-presents immense growth potential. With large agricultural sectors and a pressing need to enhance food security and crop yields, these countries are actively exploring innovative pest control technologies such as RNAi. The rising population and expanding agricultural demands further support the market's growth prospects in this region.
Recent Developments:
• In October 2023, Renaissance BioScience Corp., declared the acquisition of its first patent for its ground-breaking yeast-based platform technology intended for RNA bioactive molecule manufacturing and delivery. This patent, which was granted by the China Patent Office, expands the company's vast portfolio of intellectual property to include 50 previously awarded patents and 11 more applications that are presently pending in important international markets with positive results anticipated.
• In March 2022, Bayer, revealed the EPA's commercial registrations for the features necessary to allow its newest corn product, VT4PROTM with RNAi Technology, to be sold in the US. With the addition of VT4PROTM Technology* to Bayer's already robust corn product line, US farmers will have yet another choice for managing pesky above- and below-ground pests.
• In October 2020, AgroSpheres, announced a strategic partnership with Orion Integrated Biosciences, a globally renowned pioneer in the creation and implementation of algorithms for motif fingerprint recognition, or the identification of extremely specific genomic areas. The creation of numerous high-performing solutions in the fields of crop protection, animal health, and biodefense will be made possible by the unique RNAi alliance. Orion will produce cutting-edge, incredibly precise RNAi targets for the crop protection product line of AgroSpheres. Orion will be able to create and develop products for use in biodefense and animal health thanks to AgroSpheres' access to the AgriCell platform.
Get Specific Chapter/Information From The Report: @ https://www.insightaceanalytic.com/customisation/2799
Segmentation of RNAi Pesticides Market.
Global RNAi Pesticides Market- By Application
• Insect Pest Control
• Weed Management
• Disease Management
• Resistance Management
Global RNAi Pesticides Market - By Crop Type
• Agricultural Application
o Fruits and Vegetables
o Cereals and Grains
o Oilseed and Pulses
o Others
• Non-Agricultural Application
o Turf and Ornamentals
o Forestry
o Residential Pest Control
Global RNAi Pesticides Market - By Product
• Tropical RNAi Pesticide
• Seed Embedded RANi
• Transgenic RNAi
• Others
Global RNAi Pesticides Market - By Formulation
• Liquid Formulation
• Granular Formulation
• Powder Formulation
• Others
Global RNAi Pesticides Market - By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• Southeast Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of the Middle East and Africa
Get more information :
https://www.insightaceanalytic.com/report/rnai-pesticides-market/2799
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.https://www.insightaceanalytic.com/images_data/148861653.JPG
Contact us:
info@insightaceanalytic.com
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Twitter: https://twitter.com/Insightace
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNAi Pesticides Market Survey Detailed Analysis and Forecast 2025-2034 here
News-ID: 4001695 • Views: …
More Releases from Insightace Analytic Pvt Ltd.
Regenerative Aesthetics Exosome Products Market Top Players - BENEV, EXOCEL BIO, …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Regenerative Aesthetics Exosome Products Market- (Application (Skin Rejuvenation, Hair Restoration, Scar Reduction and Wound Healing, Anti-Inflammatory Treatments), End User (Aesthetic Clinics, Home Use, Dermatology Clinics)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Regenerative Aesthetics Exosome Products Market is expected to grow with…
Rice Bran Wax Lubricant Market expected to Witness Huge Revenue Growth to 2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Rice Bran Wax Lubricant Market - (By Grade (Food Grade, Industrial Grade, Pharmaceutical Grade), End-use (Automotive, Food and Beverage, Cosmetics and Personal Care, Pharmaceuticals, Chemicals, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Rice Bran Wax Lubricant Market is valued at US$ 394.6 million…
Refurbished Laboratory Equipment Market Key Players Analysis - Thermo Fisher Sci …
"Global Refurbished Laboratory Equipment Market - (By Product (Analytical Equipment (Chromatography Systems, Spectroscopy Instruments, Mass Spectrometers, Thermal Analyzers, Immunoassay Analyzers, Blood Gas Analyzers, Coagulation Analyzers, Others (elemental analyzers, particle size analyzers, etc.)), General Equipment (Centrifuges, Incubators, Ovens, Autoclaves, Safety cabinets, Others (balances & scales, shakers & stirrers, etc.)), Specialty Equipment (DNA Sequencers (PCR Instruments, Flow Cytometers, Microscopes, Bioreactors, Others (microplate readers, x-ray diffraction systems, etc.,)), Support Equipment), By End-User (Healthcare…
Refurbished Dental Equipment Market Top Companies Study - Superior DDS, DuraPro …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Refurbished Dental Lab Equipment Market - (By Equipment (Dental Milling, 3D Printing Systems, Integrated CAD/CAM Systems, Casting Machines, Furnaces, Articulators, Dental Scanners, Others), By End-User (Hospitals, Independent Dental Clinics, Ambulatory Surgical Centers, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Refurbished Dental Lab Equipment…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
